Companies & Industry »Company News
Lupin Ltd - Company News

BSE   26 Sep 17 | 12:45 PM

1001.55 -12 (-1.18%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 500257
Face Value: 2

NSE   26 Sep 17 | 12:39 PM

1003.05 -11.35 (-1.12%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: LUPIN
Performance
1 Week : Rs 1,005.80 (-0.42%)
1 Month : Rs 991.75 (0.99%)
1 Year : Rs 1,495.05 (-33.01%)
change companytradenow

  • 05 Jul 17
    01:26 PM
    Lupin moved higher by 4% to Rs 1,086, bouncing back 5% from intra-day low on National Stock Exchange (NSE), after the company said it has launched in the US market its generic version of Moxifloxacin Hydrochloride Ophthalmic solution used for treating
  • 25 May 17
    09:50 AM
    Shares of Lupin dipped 7.7% to Rs 1,134, its lowest level since August 2014 on BSE in early morning trade, after the company’s quarterly net profit nearly halved to Rs 380 crore in March quarter (Q4FY17) from a year ago.
  • 09 May 17
    03:25 PM
    Shares of Lupin dipped 3% to Rs 1,242, its fresh 32-month low on BSE in intra-day trade, on reported that US health regulator issued eight observations for its Aurangabad plant.
  • 28 Apr 17
    10:47 AM
    Lupin hit a fresh 52-week low of Rs 1,320, down 1.3% in intra-day trade, extending its 6.4% decline in past five trading sessions on the BSE.According to news reports, US health regulator issued Form 483 with three observations to Lupin Goa plant.
  • 30 Nov 16
    08:15 AM
    Lupin is launching generic version of sleep disorder Nuvigil tablets in the US market. The brand has an annual market size of $515 million and Lupin is the third company to launch the generic version in the US.
  • 22 Nov 16
    08:34 AM
    Nifty continues its southbound journey as it breached below its psychological support. The sequence of the lower top lower bottom continued despite an oversold situation reported by the RSI.
  • 07 Nov 16
    09:29 AM
    Lupin has surged 8% to Rs 1,535 on BSE, erasing its entire previous weeks’ losses, after the drug maker on Saturday said that it has received Establishment Inspection Report (EIR) from the US health regulator for its Goa plant leading to closure of
  • 28 Sep 16
    12:50 AM
    Drug makers Lupin, Torrent and Cadila Healthcare are considering making bids to acquire Bayer’s dermatology business, valued $1 billion.
  • 24 Aug 16
    04:02 PM
    Drug major Lupin on Wednesday said its subsidiary Gavis Pharmaceuticals has received approval from the US health regulator to market generic linezolid tablets used for treating bacterial infection in the American market.
1|2|3|4|5|6|7|8|9|10|11|Next
Widgets Magazine

Sensex

Company Price Gain (%)
O N G C170.453.65
Coal India259.802.32
Power Grid Corpn210.850.52
ICICI Bank278.550.52
Bajaj Auto3,046.950.25
Widgets Magazine

Messages

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine